98 related articles for article (PubMed ID: 2462591)
21. Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.
Norell H; Carlsten M; Ohlum T; Malmberg KJ; Masucci G; Schedvins K; Altermann W; Handke D; Atkins D; Seliger B; Kiessling R
Cancer Res; 2006 Jun; 66(12):6387-94. PubMed ID: 16778217
[TBL] [Abstract][Full Text] [Related]
22. Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
Hilders CG; Houbiers JG; van Ravenswaay Claasen HH; Veldhuizen RW; Fleuren GJ
Lab Invest; 1993 Dec; 69(6):651-9. PubMed ID: 8264228
[TBL] [Abstract][Full Text] [Related]
23. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.
Marincola FM; Shamamian P; Alexander RB; Gnarra JR; Turetskaya RL; Nedospasov SA; Simonis TB; Taubenberger JK; Yannelli J; Mixon A
J Immunol; 1994 Aug; 153(3):1225-37. PubMed ID: 8027550
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
[TBL] [Abstract][Full Text] [Related]
25. The frequency of major histocompatibility complex antigen abnormalities in urological tumours and their correction by gene transfection or cytokine stimulation.
Nouri AM; Hussain RF; Oliver RT
Cancer Gene Ther; 1994 Jun; 1(2):119-23. PubMed ID: 7621243
[TBL] [Abstract][Full Text] [Related]
26. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line.
Shimizu Y; DeMars R
J Immunol; 1989 May; 142(9):3320-8. PubMed ID: 2785140
[TBL] [Abstract][Full Text] [Related]
27. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
Wan AM; Ennis P; Parham P; Holmes N
J Immunol; 1986 Dec; 137(11):3671-4. PubMed ID: 2431040
[TBL] [Abstract][Full Text] [Related]
28. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
29. Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.
Martayan A; Fiscella M; Setini A; Ciccarelli G; Gambari R; Feriotto G; Beretta A; Siccardi AG; Appella E; Giacomini P
Hum Immunol; 1997 Mar; 53(1):23-33. PubMed ID: 9127144
[TBL] [Abstract][Full Text] [Related]
30. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
31. Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture.
Villar LM; Roy G; Lázaro I; Alvarez-Cermeno JC; González M; Brieva JA; Del la Sen ML; Leoro G; Bootello A; González-Porqué P
Eur J Immunol; 1989 Oct; 19(10):1835-9. PubMed ID: 2583224
[TBL] [Abstract][Full Text] [Related]
32. MHC antigen expression in colorectal tumours.
Smith ME
Semin Cancer Biol; 1991 Feb; 2(1):17-21. PubMed ID: 1912514
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of HLA-A and B-alleles on uveal melanoma as determined by immuno-histology.
de Waard-Siebinga I; Houbiers JG; Hilders CG; de Wolff-Rouendaal D; Jager MJ
Ocul Immunol Inflamm; 1996; 4(1):1-14. PubMed ID: 22827328
[TBL] [Abstract][Full Text] [Related]
34. Loss of polymorphic A and B locus HLA antigens in colon carcinoma.
Rees RC; Buckle AM; Gelsthorpe K; James V; Potter CW; Rogers K; Jacob G
Br J Cancer; 1988 Apr; 57(4):374-7. PubMed ID: 3291922
[TBL] [Abstract][Full Text] [Related]
35. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?
Demanet C; Mulder A; Deneys V; Worsham MJ; Maes P; Claas FH; Ferrone S
Blood; 2004 Apr; 103(8):3122-30. PubMed ID: 15070694
[TBL] [Abstract][Full Text] [Related]
37. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
[TBL] [Abstract][Full Text] [Related]
38. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
López-Nevot MA; Esteban F; Ferrón A; Gutiérrez J; Oliva MR; Romero C; Huelin C; Ruiz-Cabello F; Garrido F
Br J Cancer; 1989 Feb; 59(2):221-6. PubMed ID: 2649129
[TBL] [Abstract][Full Text] [Related]
39. Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.
Momburg F; Degener T; Bacchus E; Moldenhauer G; Hämmerling GJ; Möller P
Int J Cancer; 1986 Feb; 37(2):179-84. PubMed ID: 2417962
[TBL] [Abstract][Full Text] [Related]
40. High frequency of altered HLA class I phenotypes in invasive breast carcinomas.
Cabrera T; Angustias Fernandez M; Sierra A; Garrido A; Herruzo A; Escobedo A; Fabra A; Garrido F
Hum Immunol; 1996 Oct; 50(2):127-34. PubMed ID: 8891736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
